Ocular Pain
11 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Retrospective Review of DEXTENZA 0.4 mg inseRt Following Corneal Transplant or Cataract Surgery (NCT04975971) | Nicole Fram M.D. | 2021-03-09 |
| Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Corneal Transplant Surgery (NCT04521140) | Nicole Fram M.D. | 2020-10-16 |
| Efficacy and Safety of PRO-155 on Inflammation of the Conjunctival Surface in Subjects With Grade I-III Pterygium vs Placebo. (NCT03521791) | Laboratorios Sophia S.A de C.V. | 2017-12-13 |
| Dose-finding Study to Assess the Safety and Effect of SYL1001 in Patients With Ocular Pain (NCT02455999) | Sylentis, S.A. | 2015-06-01 |
| RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD (NCT02128113) | Biogen | 2014-05-31 |
| Pilot Study to Evaluate SYL1001 Safety and Effect in Patients With Ocular Pain (NCT01776658) | Sylentis, S.A. | 2012-11-01 |
| Study to Evaluate the Ocular Tolerance of SYL1001 in Healthy Volunteers (NCT01438281) | Sylentis, S.A. | 2011-07-01 |
Track Ocular Pain automatically
Every clearance here is in the API, with alerts when new ones post.